BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 12043108)

  • 1. Current treatment of cutaneous melanoma and the sentinel lymph node.
    Bruns SD; McGee JM; Phillips JW
    J Okla State Med Assoc; 2002 May; 95(5):332-5. PubMed ID: 12043108
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Wong SL
    Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sentinel lymph node biopsy and incidence of recurrence].
    Hautarzt; 2006 Mar; 57(3):182. PubMed ID: 17429861
    [No Abstract]   [Full Text] [Related]  

  • 4. The popliteal fossa - a problem zone for sentinel lymphonodectomy.
    Kretschmer L; Sahlmann CO; Bardzik P; Thoms KM; Bertsch HP; Meller J
    J Dtsch Dermatol Ges; 2011 Feb; 9(2):123-7. PubMed ID: 21040471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous melanoma: practical usefulness of the American Joint Committee on Cancer staging system.
    Sober AJ
    Dermatol Ther; 2005; 18(6):407-11. PubMed ID: 16297016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in thin melanoma patients.
    Hershko DD; Robb BW; Lowy AM; Ahmad SA; Ramadas GH; Soldano DA; Sussman JJ
    J Surg Oncol; 2006 Mar; 93(4):279-85. PubMed ID: 16496355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial.
    Thomas JM
    J Clin Oncol; 2005 Dec; 23(36):9443-4. PubMed ID: 16361650
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
    Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
    Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
    Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
    Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of melanoma micrometastases in the sentinel lymph node.
    Giblin AV; Hayes AJ; Thomas JM
    Eur J Surg Oncol; 2005 Dec; 31(10):1103-4. PubMed ID: 16084052
    [No Abstract]   [Full Text] [Related]  

  • 13. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
    Gutzmer R; Satzger I; Thoms KM; Völker B; Mitteldorf C; Kapp A; Bertsch HP; Kretschmer L
    J Dtsch Dermatol Ges; 2008 Mar; 6(3):198-203. PubMed ID: 18093216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
    Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is sentinel node status predictive of overall survival in patients with melanoma?
    Carlson GW
    Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
    [No Abstract]   [Full Text] [Related]  

  • 17. A glimpse of future management of melanoma.
    Cochran AJ
    Arch Dermatol; 2009 Oct; 145(10):1176-7. PubMed ID: 19841407
    [No Abstract]   [Full Text] [Related]  

  • 18. Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy.
    Caracò C; Marone U; Botti G; Celentano E; Lastoria S; Mozzillo N
    Eur J Surg Oncol; 2006 Nov; 32(9):970-3. PubMed ID: 16996239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.
    Pearlman NW; McCarter MD; Frank M; Hurtubis C; Merkow RP; Franklin WA; Gonzalez R; Lewis K; Roaten JB; Robinson WA
    Am J Surg; 2006 Dec; 192(6):878-81. PubMed ID: 17161112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free.
    Wasserberg N; Tulchinsky H; Schachter J; Feinmesser M; Gutman H
    Eur J Surg Oncol; 2004 Oct; 30(8):851-6. PubMed ID: 15336731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.